Novavax Inc. Stock Rises 15.8%, Outperforms Peers

Dow Jones2026/10/09 20:33

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Novavax Inc. climbed 15.8% to $12.75 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 27,366.17 and the Dow Jones Industrial Average rising 0.8% to 51,654.95. The stock's rise snapped a three-day losing streak. Novavax Inc. closed 4.7% below its 52-week high of $13.39, which the company reached on October 5th. The stock outperformed some of its peers, as Johnson & Johnson rose 1.9% to $261.44, Pfizer Inc. rose 1.7% to $28.28, and Merck & Co. Inc. rose 2.26% to $145.60. Trading volume totaled 18.9 million, compared to the 50-day average of 5.8 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 09, 2026 16:33 ET (20:33 GMT)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.